1. Home
  2. ALOT vs ANL Comparison

ALOT vs ANL Comparison

Compare ALOT & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALOT
  • ANL
  • Stock Information
  • Founded
  • ALOT 1969
  • ANL 2004
  • Country
  • ALOT United States
  • ANL Cayman Islands
  • Employees
  • ALOT N/A
  • ANL N/A
  • Industry
  • ALOT Computer peripheral equipment
  • ANL
  • Sector
  • ALOT Technology
  • ANL
  • Exchange
  • ALOT Nasdaq
  • ANL Nasdaq
  • Market Cap
  • ALOT 81.6M
  • ANL 81.9M
  • IPO Year
  • ALOT N/A
  • ANL 2023
  • Fundamental
  • Price
  • ALOT $9.07
  • ANL $2.05
  • Analyst Decision
  • ALOT
  • ANL Strong Buy
  • Analyst Count
  • ALOT 0
  • ANL 2
  • Target Price
  • ALOT N/A
  • ANL $9.00
  • AVG Volume (30 Days)
  • ALOT 13.1K
  • ANL 6.8K
  • Earning Date
  • ALOT 04-14-2025
  • ANL 04-08-2025
  • Dividend Yield
  • ALOT N/A
  • ANL N/A
  • EPS Growth
  • ALOT 12.82
  • ANL N/A
  • EPS
  • ALOT 0.51
  • ANL N/A
  • Revenue
  • ALOT $153,515,000.00
  • ANL $5,000,000.00
  • Revenue This Year
  • ALOT N/A
  • ANL N/A
  • Revenue Next Year
  • ALOT N/A
  • ANL N/A
  • P/E Ratio
  • ALOT $17.60
  • ANL N/A
  • Revenue Growth
  • ALOT 3.48
  • ANL N/A
  • 52 Week Low
  • ALOT $8.33
  • ANL $1.85
  • 52 Week High
  • ALOT $18.25
  • ANL $17.48
  • Technical
  • Relative Strength Index (RSI)
  • ALOT 33.12
  • ANL 38.59
  • Support Level
  • ALOT $8.33
  • ANL $2.02
  • Resistance Level
  • ALOT $9.29
  • ANL $2.49
  • Average True Range (ATR)
  • ALOT 0.52
  • ANL 0.14
  • MACD
  • ALOT -0.12
  • ANL -0.02
  • Stochastic Oscillator
  • ALOT 19.93
  • ANL 7.22

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: